Results 101 to 110 of about 4,465 (182)

Cardiac Safety of Intranasal Chlorpheniramine: An Exposure-Based Risk Assessment. [PDF]

Pharmaceuticals (Basel)
Alas-Pineda C, Pavón-Varela DJ, Gaitán-Zambrano K, Ferrer G.   +3 more
europepmc   +1 more source

Interactions of the H1 antihistamines.

Journal of investigational allergology & clinical immunology, 2007
J, Bartra, A L, Valero, A, del Cuvillo, I, Dávila, I, Jáuregui, J, Montoro, J, Mullol, J, Sastre   +7 more
openaire   +1 more source

Real-world efficacy and safety of omalizumab in chronic spontaneous urticaria: Insights from the Middle East. [PDF]

J Allergy Clin Immunol Glob
Elkhalifa S, Mahmoud E, Salvo F, AlHameli H, Cerecedo I, Shafiq I, Abuzakouk M.   +6 more
europepmc   +1 more source

Correction: Dupilumab Reduces Pruritus in Clinically Distinct Dermatologic Diseases: Data from Clinical Trials on Atopic Dermatitis, Prurigo Nodularis, and Chronic Spontaneous Urticaria. [PDF]

Dermatol Ther (Heidelb)
Yosipovitch G, Kim BS, Koo JY, Chen Z, Wiggins S, Zahn J, Sugerman P, Haddad EB, Cyr SL.   +8 more
europepmc   +1 more source

Advancements and challenges in the management of chronic inducible urticaria. [PDF]

Front Immunol
Zhang M, Liu J, Zhi Y.
europepmc   +1 more source

Impact of Antihistamines on Sleep, Cognition, and Daily Functioning: Evidence From Primary and Community Care. [PDF]

J Prim Care Community Health
Jaradat O, Awad A, Abu Samaan H, Al-Toom S, Alsadder T, Jaber M, Shawahna R.   +6 more
europepmc   +1 more source

Expanding treatment options in chronic spontaneous urticaria: the emerging role of dupilumab. [PDF]

Ann Med Surg (Lond)
Fathima Haseena H, Kumari S, Jaber Amin MH.   +2 more
europepmc   +1 more source

Delayed urticaria during treatment with anti-CGRP monoclonal antibodies in migraine. [PDF]

Headache
Berger CT, Villena FB, Vogt SB, Heydrich L, Hartmann K, Papadopoulou A.   +5 more
europepmc   +1 more source

Restless Legs Syndrome Associated With Fexofenadine Use: A Case Report. [PDF]

Clin Case Rep
Albeshry AM.
europepmc   +1 more source

Bilastine: a new nonsedating oral H1 antihistamine for treatment of allergic rhinoconjunctivitis and urticaria. [PDF]

Biomed Res Int, 2013
Wolthers OD.
europepmc   +1 more source